RARRES3 Antibody

Code CSB-PA911568
Size US$166
Order now
  • The image on the left is immunohistochemistry of paraffin-embedded Human colon cancer tissue using CSB-PA911568(RARRES3 Antibody) at dilution 1/25, on the right is treated with fusion protein. (Original magnification: ×200)
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Uniprot No.
Target Names
Alternative Names
HRASLS4 antibody; MGC8906 antibody; RAR responsive protein TIG3 antibody; RAR-responsive protein TIG3 antibody; RARRES3 antibody; Retinic acid inducible gene 1 antibody; Retinoic acid receptor responder (tazarotene induced) 3 antibody; Retinoic acid receptor responder protein 3 antibody; Retinoid inducible gene 1 protein antibody; Retinoid-inducible gene 1 protein antibody; RIG 1 antibody; rig1 antibody; Tazarotene induced gene 3 protein antibody; Tazarotene-induced gene 3 protein antibody; TIG 3 antibody; TIG3 antibody; TIG3_HUMAN antibody
Raised in
Species Reactivity
Fusion protein of Human RARRES3
Immunogen Species
Homo sapiens (Human)
Purification Method
Antigen affinity purification
It differs from different batches. Please contact us to confirm it.
-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
Tested Applications
Recommended Dilution
Application Recommended Dilution
ELISA 1:2000-1:5000
IHC 1:25-1:100
Troubleshooting and FAQs
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Exhibits both phospholipase A1/2 and acyltransferase activities. Shows phospholipase A1 (PLA1) and A2 (PLA2), catalyzing the calcium-independent release of fatty acids from the sn-1 or sn-2 position of glycerophospholipids. For most substrates, PLA1 activity is much higher than PLA2 activity. Shows O-acyltransferase activity, catalyzing the transfer of a fatty acyl group from glycerophospholipid to the hydroxyl group of lysophospholipid. Shows N-acyltransferase activity, catalyzing the calcium-independent transfer of a fatty acyl group at the sn-1 position of phosphatidylcholine (PC) and other glycerophospholipids to the primary amine of phosphatidylethanolamine (PE), forming N-acylphosphatidylethanolamine (NAPE), which serves as precursor for N-acylethanolamines (NAEs). Promotes keratinocyte differentiation via activation of TGM1.
Gene References into Functions
  1. RIG-I and MDA5 receptor sensing of host non-coding RNAs facilitates the cell-intrinsic immune response to Kaposi's sarcoma-associated herpesvirus infection. PMID: 30451863
  2. we observed frameshift mutations of RARRES3 in 11 cases of colorectal cancer PMID: 29496306
  3. Data demonstrate that RIG-1 is activated after mitochondrial SUMOylation by MAPL which is an essential process for the mitochondrial antiviral signaling response. PMID: 28273895
  4. Low RIG1 expression is associated with Arenaviral infections. PMID: 29669840
  5. Conclusively, these data demonstrate the MCPIP1 contributes to attenuate influenza A virus-induced host antiviral response by suppressing RIG-I expression. PMID: 28892164
  6. Oncostatin M induces RIG-I and MDA5 expression and enhances the double-stranded RNA response in fibroblasts. PMID: 28560754
  7. Identified the tumor suppressor RARRES3 as a critical target of G9a. Epigenetic silencing of RARRES3 contributed to the tumor-promoting function of G9a PMID: 28532996
  8. Results provide evidence that RIG-I as an essential mediator for influenza A virus-induced COX-2 expression. PMID: 27265729
  9. perifascicular pattern of RIG-I expression supports the diagnosis of dermatomyositis PMID: 28738907
  10. The current study establishes that hypoxia can profoundly influence the inducible RIG-I protein expression in malignant cells of both human and murine origin, whereas this phenomenon was not identified in nonmalignant cell lines or primary cells. PMID: 28468914
  11. our study demonstrates that the novel pathway lncRNA Ftx/miR-545/RIG-I promotes hepatocellular carcinoma development PMID: 26992218
  12. this review describes antiviral activities of RIG-I against influenza viruses (standing on three legs) PMID: 27318973
  13. Study uncovered a novel aspect of Rig-I in monitoring gut microbiota through regulating IgA and IL6-STAT3-dependent Reg3gamma pathway. Besides, Rig-I loss could also promote colorectal cancer progression both in the presence and absence of intestinal bacteria. PMID: 28057020
  14. a novel mechanism of pattern recognition receptor modulation by HCV and suggests a biological function of the HCV alternate reading frame in the modulation of host innate immunity PMID: 27404108
  15. this study indicated that increased expression of TIG3 in primary glioblastoma is a novel biomarker for predicting poor outcome of patients. We then hypothesize that TIG3 may function in a different pattern in glioblastoma PMID: 28639915
  16. Foot-and-mouth disease virus Viroporin 2B antagonizes RIG-I-mediated antiviral effects by inhibition of its protein expression. PMID: 27707918
  17. Overexpression of TIG3 suppresses tumor growth in hepatocellular carcinoma PMID: 26951515
  18. miR-34a is an antioncogene in multiple tumors, in this study, RIG-I and miR-34a suppressed cell growth, proliferation, migration, and invasion in cervical cancer cells in vitro. miR-34a was validated as a new regulator of RIG-I by binding to its 3' untranslated region and upregulating its expression level. PMID: 26910120
  19. TRIM25 plays an additional role in RIG-I/MDA5 signaling other than RIG-I ubiquitination via activation of NF-kappaB. PMID: 26299329
  20. These observations highlight the importance of RIG-I signaling in anti-HIV innate immunity in macrophages, which may be beneficial for the treatment of HIV and aid in the understanding of the neuropathogenesis of HAND. PMID: 26535695
  21. Gal1 and gal3 regulate the inflammatory response in airway epithelial cells exposed to microbial neuraminidase by modulating the expression of SOCS1 and RIG1. PMID: 26355912
  22. findings provide a new insight into the molecular link between p53, protein acylation and Wnt/beta-catenin signaling whereby RARRES3 plays a pivotal role in modulating the acylation status of signaling proteins. PMID: 25361079
  23. During Crimean-Congo hemorrhagic fever virus infection, RIG-I mediated a type I interferon response via MAVS. PMID: 26223644
  24. the flexible main loop of H-REV107, but not that of TIG3, is critical for its NTD to modulate its CTD in inducing cell death. PMID: 25871522
  25. Viral pseudo-enzymes activate RIG-I via deamidation to evade cytokine production. PMID: 25752576
  26. critical for the initiation of IRF-3 phosphorylation, dimerization and downstream gene expression during antiviral innate immune response PMID: 24800889
  27. RARRES3 downregulation engages metastasis-initiating capabilities by facilitating adhesion of the tumor cells to the lung parenchyma. PMID: 24867881
  28. MiR-545 exerts its effects in pancreatic ductal adenocarcinoma by directly targeting RIG-1 PMID: 25315416
  29. These findings argue that TIG3 is involved in the control of keratinocyte differentiation and that loss of TIG3 in transformed cells contributes to the malignant phenotype. PMID: 24599174
  30. We show that the C-terminal hydrophobic domain targets intact TIG3 to the plasma membrane, but when isolated as an independent element localizes at the mitochondria and a segment of the N-terminal hydrophilic region targets the centrosome. PMID: 24401997
  31. Low RIG1 expression is associated with testis cancer. PMID: 22960220
  32. RIG1 gene is a downstream target of p53 in cancer cell lines PMID: 22616991
  33. Data suggest that pericentrosomal localization of TIG3 is a key event that results in microtubule and microfilament redistribution and pericentrosomal organelle clustering and that leads to cancer cell apoptosis. PMID: 21858038
  34. We conclude that TG1-catalysed cross-linking, regulated by TIG3, might play an important role in the formation of neuronal tau inclusions in certain tauopathies PMID: 22009441
  35. induction of TIG3 is associated with the suppression of anchorage-independent growth in certain aerodigestive tract cancer cells PMID: 12879006
  36. TIG3 facilitates the terminal stages in keratinocyte differentiation via activation of type I transglutaminase PMID: 12928434
  37. altered RARRES3 expression may play a role in the carcinogenesis of the liver and biliary tract. PMID: 15742394
  38. identification and characterization of the functional RA response element that is responsible for the RA-mediated induction of RIG1 gene PMID: 15850806
  39. TIG3 is negatively regulated by an activated MEK-ERK signaling pathway in ovarian carcinoma. PMID: 15856468
  40. The proapoptotic and anti-RAS activities of RIG1 are primarily associated with the Golgi localization of the protein. PMID: 17196792
  41. the TIG3 N-terminal region is required for TIG3-dependent keratinocyte differentiation, and its removal converts TIG3 into a proapoptotic protein PMID: 17762858
  42. The NC domain, especially the NC motif, plays the major role in RIG1-mediated pro-apoptotic activity. The RIG1(111-123) dodecapeptide exhibited strong pro-apoptotic activity and has potential as an anticancer drug. PMID: 19245694
  43. The tumor suppressors TIG3, HRASLS2 and H-rev107 are involved in the phospholipid metabolism with different physiological roles. PMID: 19615464

Show More

Hide All

Subcellular Location
Membrane; Single-pass membrane protein.
Protein Families
H-rev107 family
Tissue Specificity
Widely expressed.
Database Links

HGNC: 9869

OMIM: 605092

KEGG: hsa:5920

STRING: 9606.ENSP00000255688

UniGene: Hs.17466

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details


II. Contact details


III. Ship To


IV. Bill To